Displaying 1 - 10 of 15 for Geriatrics
  • ADSPAM Study (H-36346)
    • The purpose of this study is to find the largest safe dose of donor-derived tumor protein multi-TAA-specific T cells for patients with AML or MDS.
  • CARPASCIO Study (H-33133)
    • The purpose of this study is to see whether this therapy might help people with lymphoma or leukemia after a stem cell transplantation from a donor.
  • CHARMS Study (H-33903)
    • Investigators want to see if they can use banked multivirus-specific T cells to treat infections of these viruses after a transplant: Epstein Barr virus (EBV), cytomegalovirus (CMV), BK virus, JC virus, adenovirus or HHV6 (Human Herpes Virus 6).
  • Glioblastoma (iCAR) Study (H-31973)
    • The purpose of this study is to find the largest safe dose of HER2-CAR T cells, to learn what the side effects are, and to see whether this experimental intervention might help patients with glioblastoma.
  • GRALE Study (H-29617)
    • The purpose of this study is to find the largest safe dose of LMP-specific cytotoxic GRALE T cells created using this new manufacturing technique.
  • HPV-Related Cancer Study (H-36021)
    • The purpose of this study is to find the biggest dose of HPVSTs that is safe, to see how long they last in the body, to learn what the side effects are and to see if the HPVSTs will help people with HPV associated cancers.
  • MABEL Study (H-35253)
    • In this study, we want to find out if we can use banked MABEL CTLs to treat HD or NHL, T/NK-lymphoproliferative disease and severe chronic active Epstein Barr Virus (CAEBV).
  • PREVALE Study (H-39090)
    • The purpose of this study is to find out if LMP-specific EB-VST cells in combination with nivolumab are safe, to learn what the side effects are, and to see whether this therapy may help patients with EBV related lymphoma or LPD.
  • RELY-30 Study (H-37966)
    • In this study lymphodepletion chemotherapy will be administered in patients who are not post autologous transplant in the hope that it will result in more durable anti-tumor effects.
  • RESIST-NPC Study (H-33954)
    • This study is a gene transfer research study using special immune cells for patients diagnosed with nasopharyngeal carcinoma (NPC).